Getting New Drug Modalities to Market: How Can Your Data Strategy Help?
This article highlights the role of data strategies in accelerating the development of new drug modalities
Search Results
Empowering Scientists: The Revvity Signals Approach
Revvity Signals was first-to-market with SaaS software and integrates AI to help empower scientists. Read our interview with David Gosalvez to learn the future vision of Revvity Signals.
Revvity Ignites Scientific Breakthroughs at SLAS 2025
Revvity introduces groundbreaking Phenologic.AI software at SLAS 2025, transforming cellular imaging workflows and showcasing innovative life sciences solutions for drug discovery and development.
The Lab of the Future is Now
Revvity Signal understands the opportunities that accompany creating the lab of the future. Our SaaS solutions helps businesses leverage modern technologies, including AI and ML.
The Impact of Software Platforms on CRO and Biopharma Partnerships | Revvity Signals Software
Signals Synergy enhances collaboration and information between CROs and sponsors. Learn how Signals Synergy improves communication and project management with CROs.
AI-Powered Drug Discovery Possibilities | Revvity Signals Software
Revvity Signals helps take advantage of AI-ready data within antibody drug discovery. Learn how Signals Research Suite can help accelerate scientific.
